Cargando…
Clinical outcome of primary giant cell tumor of bone after curettage with or without perioperative denosumab in Japan: from a questionnaire for JCOG 1610 study
BACKGROUND: Giant cell tumor of bone (GCTB) is an intermediate tumor known to be locally aggressive, but rarely metastasizing. To plan a prospective study of GCTB, we performed a questionnaire survey for institutions participating in the Bone and Soft Tissue Tumor Study Group (BSTTSG) in the Japan C...
Autores principales: | Urakawa, Hiroshi, Yonemoto, Tsukasa, Matsumoto, Seiichi, Takagi, Tatsuya, Asanuma, Kunihiro, Watanuki, Munenori, Takemoto, Akira, Naka, Norifumi, Matsumoto, Yoshihiro, Kawai, Akira, Kunisada, Toshiyuki, Kubo, Tadahiko, Emori, Makoto, Hiraga, Hiroaki, Hatano, Hiroshi, Tsukushi, Satoshi, Nishida, Yoshihiro, Akisue, Toshihiro, Morii, Takeshi, Takahashi, Mitsuru, Nagano, Akihito, Yoshikawa, Hideki, Sato, Kenji, Kawano, Masanori, Hiraoka, Koji, Tanaka, Kazuhiro, Iwamoto, Yukihide, Ozaki, Toshifumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6083623/ https://www.ncbi.nlm.nih.gov/pubmed/30089488 http://dx.doi.org/10.1186/s12957-018-1459-6 |
Ejemplares similares
-
Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus docetaxel for high-risk soft tissue sarcomas: randomised, phase II/III study JCOG1306
por: Tanaka, Kazuhiro, et al.
Publicado: (2022) -
Ten-year follow-up results of perioperative chemotherapy with doxorubicin and ifosfamide for high-grade soft-tissue sarcoma of the extremities: Japan Clinical Oncology Group study JCOG0304
por: Tanaka, Kazuhiro, et al.
Publicado: (2019) -
Prospective comparison of various radiological response criteria and pathological response to preoperative chemotherapy and survival in operable high-grade soft tissue sarcomas in the Japan Clinical Oncology Group study JCOG0304
por: Tanaka, Kazuhiro, et al.
Publicado: (2018) -
Phase II trial of pazopanib in patients with metastatic or unresectable chemoresistant sarcomas: A Japanese Musculoskeletal Oncology Group study
por: Urakawa, Hiroshi, et al.
Publicado: (2020) -
Genomic landscape and its prognostic significance in stage III colorectal cancer: JCOG1506A1, an ancillary of JCOG0910
por: Shida, Dai, et al.
Publicado: (2023)